Acceleron Pharma Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Acceleron Pharma Inc with three other
companies in this sector in UNITED STATES :
Teligent Inc (NEW JERSEY)
sales of $65.90 million
of which 70%
of which 100%
was Synthetic Biology), and
Xtant Medical Holdings Inc
of which 72%
Sales increased substantially in 2019:
Acceleron Pharma Inc reported sales of $73.99 million
December of 2019.
increase of 428.9%
versus 2018, when the company's sales were $13.99 million.